癌におけるパノプトーシス:分子メカニズムと治療の可能性
Xi Pu1,2, Yuting Wu1, Chen Peng3
1Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China.
Cancer gene therapy
|August 21, 2025
まとめ
新しい細胞死経路であるPANOPTOSISは,ピロプトーシス,アポプトーシス,そしてネクロティック細胞死を統合しています. パノプトーシスの理解は,腫瘍の発症,進行,免疫におけるその役割をターゲットにすることで,がんに対する新しい治療戦略を提供します.
科学分野:
- 細胞生物学
- 免疫学
- 腫瘍学
背景:
- 腫瘍形成は細胞死と関連している.
- PANoptosisは,プログラムされた細胞死経路が新たに特定されました.
- PANオプトシスは,パイロプトシスとアポプトシスの特徴を統合するPANオプトソーム複合体を含みます.
研究 の 目的:
- PANoptosisの特徴とメカニズムをレビューする.
- ガン生物学と腫瘍免疫における PANoptosis の役割を議論する.
- PANoptosisを標的とした治療戦略を探求する.
主な方法:
- プログラムされた細胞死経路の文献レビュー
- パノプトーシスの構成と分子特性の分析
- PANoptosisががんと免疫に及ぼす影響について
主要な成果:
- パノプトーシスは,ピロプトーシス,アポプトーシス,そして死滅性細胞の特徴を統合する.
- PANオプトソームは,PANオプトーシスの主要な多タンパク質複合体である.
- PANOPTOSISは,がんの発症,進行,そして腫瘍の微小環境に影響を与えます.
結論:
- PANoptosisは癌の生物学において重要な役割を果たしています.
- PANoptosisをターゲットにすることは,がん治療の有望な治療法です.
- PANOPTOSISに関するさらなる研究は 癌治療に革命をもたらすでしょう
関連する概念動画
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Non-Canonical Wnt Signaling Pathways
7.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Canonical Wnt Signaling Pathway
8.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


